Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Exclusive: 4 Life Science Companies Merge into Discovery Life Sciences

Discovery Life Sciences, a leading research biobank located in Los Osos, California, recently got much larger via a four-company merger. Ann Dover, Discovery’s founder, president and CEO, spoke with BioSpace about the merger and biobank’s new identity.

Read More »

Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs

Sanofi is reportedly eying a significant expansion in Cambridge, Mass., that could spur a hiring spree. In Portland, Oregon, Genentech is looking to open an office space that would require up to 300 new hires, The Portland Business Journal reported.

Read More »

FDA approves Pfizer’s breast cancer drug Talzenna

The U.S. Food and Drug Administration approved Pfizer Inc.’s Talzenna (talazoparib) for an advanced form of breast cancer.

Read More »

Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU

Rival versions of the world’s top-selling drug – AbbVie’s Humira – went on sale in Europe, years ahead of similar cut-price copies being available in the United States.

Read More »

J&J beats profit estimates, lifts outlook on pharma unit strength

Johnson & Johnson reported slightly better-than-expected third-quarter 2018 profit and raised the company’s full-year forecast.

Read More »

Late-stage Dupixent trials show positive results

Drugmakers Sanofi and Regeneron received positive results for Dupixent, which treats eczema and is seen as a key driver of future revenues.

Read More »

U.S. to propose TV drug ads must include list prices

The U.S. government, in an effort to increase pressure on drugmakers to lower costs for U.S. consumers, will propose requiring companies to include the price of Rx medicines in TV ads.

Read More »

AstraZeneca will keep UK investment freeze if no Brexit clarity

AstraZeneca will keep the company’s freeze on manufacturing investments in Britain if the country’s exit from the European Union fails to give enough clarity on future trading relations, the drugmaker’s chairman was quoted as saying.

Read More »

Hip and knee surgeons to use Apple Watch to monitor patients

Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by prosthetic limb specialist Zimmer Biomet.

Read More »

Novo Nordisk hires AstraZeneca executive

Novo Nordisk is in advanced talks to acquire assets to bolster the company’s struggling biopharma business after the drugmaker announced the hiring of an AstraZeneca executive to head the unit.

Read More »

SQZ, Roche reach expansion deal of up to $1 billion

Watertown, Mass.-based SQZ Biotechnologies could be on the receiving end of up to $1 billion following the company’s signing of an expansion agreement with pharma giant Roche.

Read More »

FDA Advisory Committee Recommends AcelRx’s Opioid Drug Dsuvia

The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee voted to recommend AcelRx Pharmaceuticals’ Dsuvia to manage moderate-to-severe pain.

Read More »

Up-and-Coming Automation Company Berkeley Lights Raises $95 Million

Emeryville, Calif.-based Berkeley Lights closed on a $95 million financing round, led by Nikon.

Read More »

International aid saves 700 million lives but gains at risk: report

International aid financing and innovation has helped to save nearly 700 million lives in the past 25 years, but those gains could be lost if momentum and political will wane, global health experts said.

Read More »

Global Biopharma Companies Top Forbes’ List of World’s Best Employers

Forbes’ 2018 ranking of the “World’s Best Employers” includes a number of global biopharmaceutical companies.

Read More »

Using Lab-Grown Retinas, Researchers Take Steps Toward Curing Colorblindness

Researchers at Johns Hopkins University, the University of California, San Diego (UCSD), and the National Institute of Mental Health grew retinas in Petri dishes and discovered fundamental factors involved in the development of vision and color vision.

Read More »

U.S. appeals court upholds ruling that canceled Teva Copaxone patents

A U.S. appeals court upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd. on the blockbuster multiple sclerosis drug Copaxone.

Read More »

Opdivo fails to meet lung cancer study goal

Bristol-Myers Squibb’s blockbuster cancer drug Opdivo failed to meet the main goal in a late-stage trial on patients with a type of lung cancer, whose condition had relapsed after chemotherapy.

Read More »

AbbVie settles Humira patent disputes with Sandoz

AbbVie Inc. settled all patent disputes with Novartis AG, granting the Swiss drugmaker a non-exclusive license to manufacture and sell a copycat version of the blockbuster drug Humira.

Read More »

Jury clears J&J of liability in NJ talc cancer case

A New Jersey jury cleared J&J of liability in a case involving a woman who alleged that the company’s talc-based products, including baby powder, contain asbestos and caused her cancer.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom